Correction: So-Young International Inc.
Financial Performance: So-Young International Inc. reported total revenues of RMB378.7 million (US$52.9 million) for Q2 2025, a decrease from RMB407.4 million in Q2 2024, with a net loss of RMB36.0 million compared to a net income of RMB18.9 million in the same period last year.
Aesthetic Treatment Services Growth: Revenues from aesthetic treatment services surged to RMB144.4 million (US$20.2 million), marking a 426.1% increase from RMB27.4 million in Q2 2024, driven by the expansion of branded aesthetic centers.
Operational Highlights: The number of verified treatment visits exceeded 67,400, and active users reached over 100,400, showcasing significant growth in consumer engagement and service utilization.
Future Outlook: For Q3 2025, So-Young anticipates aesthetic treatment service revenues between RMB150.0 million and RMB170.0 million, reflecting an expected increase of 230.5% to 274.6% compared to the same quarter in 2024.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on SY
About SY
About the author
So-Young's Transformation Journey Creates Conflicting Reactions
Company Transformation: So-Young International Inc. has shifted from an online community and e-commerce platform to operating the largest chain of "light medical aesthetic clinics" in China, with significant revenue growth from this new venture.
Financial Performance: Despite a 305% increase in revenue from its clinics, So-Young reported a net loss of 64.3 million yuan in the latest quarter due to a sharp decline in its older online business, raising concerns about the sustainability of its dual business model.
Expansion Plans: The company aims to expand its clinic network to 50 centers by the end of the year and has a long-term goal of establishing 1,000 centers across China within the next 8 to 10 years.
Market Dynamics: So-Young's transition away from online services may reduce competition with internet giants but introduces new challenges from emerging rivals in the medical aesthetics sector, as the market is projected to grow significantly by 2030.
Burning Rock Shares Surge Over 35% as Losses Decrease
Revenue Growth: Burning Rock's revenue increased by 2.3% in the third quarter, primarily driven by a significant rise in R&D services, despite declines in its core cancer diagnostic products.
Stock Performance: The company's stock has tripled this year, with a notable 33% increase following its latest earnings report, reflecting investor optimism about its high gross margins and potential path to profitability.
Financial Challenges: Despite the revenue growth, Burning Rock continues to face high operating expenses, which accounted for 87% of its revenue, leading to a net loss that, while narrowed, still indicates ongoing financial struggles.
Market Position: The company has received approval for some products in Japan as companion diagnostics, but its global revenue remains weak, highlighting the uncertainty surrounding its growth prospects compared to other successful Chinese stocks.
